RheodX, the CRM’s spin-off launched through The Collider programme

Jul 19, 2018



Barcelona – Wednesday, 18/07/18 – The Collider technology transfer programme, launched by the Mobile World Capital Barcelona, has completed its first cycle of action with the creation of 4 spin-offs n the fields of big data, IoT, and blockchain. In this first edition, more than 300 entrepreneurs  from 41 countries, and more than 50 applications from scientists from 12 different nationalities were presented. From all these candidates, 24 participants were selected (16 entrepreneurs and 8 scientists) and created 8 work groups.

One of the spin-offs that came through this first phase of the programme is RheoDx, the project that emerged from the Centre de Recerca Matemàtica and became a spin-off after passing through The Collider. Led by the biologist Samantha López, the telecommunications engineer Joan Grasas and the financier Oliver Balcells, RheoDx is a portable in-vitro device for immediate diagnosis of haematological diseases using just one drop of blood.

The device, which combines microfluidic technology with big data to detect anomalies in blood cells, even now, in its pilot phase, involves institutions such as the Blood and Tissue Bank, the Josep Carreras Institute and Hospital Clínic.
You can listen to a small interview with Samantha López by clicking here (source Rac1).